Journal of Isfahan Medical School

Journal of Isfahan Medical School

Comparing the Hemodynamic Effects of Nitroglycerin and Labetalol Infusion for Hypertension and Heart Rate Control Before and During Induction to Cardiopulmonary Arrest in Patients Under Coronary Artery Bypass Graft

Document Type : Original Article (s)

Authors
Gholamreza Masoumi 1
Maryam Toloueghamari 2
1 Assistant Professor, Anesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
2 Resident, Department of Anesthesiology and Critical Care. School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
Abstract
Background: This study was aimed to compare the hemodynamic effects of nitroglycerin and labetalol infusion for hypertension and heart rate control in the before and during induction to cardiopulmonary arrest in patients under coronary artery bypass graft.Methods: In a clinical trial study, 70 candidates for coronary bypass were selected and randomly divided in the two groups. In the first group nitroglycerin and in the second group labetalol was injected and hemodynamic changes, blood gas levels, incidence of arythmia during and after surgery was measured. Also amount of anti-arythmic drugs, inotrop, pack cell and DC shock need were studied and compared between the two groups.Findings: Incidence of cardiac arrhythmia in the nitroglycerin and labetalol was 9 and 5 (25.7% VS 3.14%) (P = 0.370), also need to anti-arrhythmic drugs in the two groups was 22.9% and 2.9%, respectively (P = 0.028).Conclusion: Using labetalol in patients under coronary artery bypass graft is better than nitroglycerin for hemodynamic and blood gases. Also, incidence of cardiac arrhythmia during cardiopulmonary arrest is lower and labetalol is preferred to nitroglycerin and recommended according to surgeons and anesthesiologists.
Keywords
Coronary artery bypass grafting (CABG)
Blood Pressure
Nitroglycerin
Labetalol
  1. Roger VL. Epidemiology of myocardial infarction. Med Clin North Am 2007; 91(4): 537-52.
  2. Kaplan JA, Reich DL, Savino JS. Kaplan's cardiac anesthesia. 6th ed. Philadelphia, PA: Saunders; 2011. P. 2115-36.
  3. Miller RD, Eriksson LI, Fleisher LA, Wiener-Kronish JP, Young WL. Miller's anesthesia. 7th ed. Philadelphia, PA: Elsevier; 2009. p. 286-290.
  4. Lee SC, Fung ST, Lee JH. Effects of labetalol and nitroglycerin during induction of anesthesia and endotracheal intubation in hypertensive patients. Ma Zui Xue Za Zhi 1989; 27(3): 247-54. [In Chinese].
  5. Borzak S. Intravenous nitroglycerin for acute myocardial infarction. Henry Ford Hosp Med J 1991; 39(3-4): 206-9.
  6. Fukuyama T, Roberts R. The effect of intravenous nitroglycerin on coronary blood flow and infarct size during myocardial infarction in conscious dogs. Clin Cardiol 1980; 3(5): 317-23.
  7. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985; 27(5): 335-71.
  8. Kezerashvili A, Marzo K, De LJ. Beta blocker use after acute myocardial infarction in the patient with normal systolic function: when is it "ok" to discontinue? Curr Cardiol Rev 2012; 8(1): 77-84.
  9. Chatterjee S, Chaudhuri D, Vedanthan R, Fuster V, Ibanez B, Bangalore S, et al. Early intravenous beta-blockers in patients with acute coronary syndrome--a meta-analysis of randomized trials. Int J Cardiol 2013; 168(2): 915-21.
  10. Timmis AD, Fowler MB, Jaggarao NS, Vincent R, Chamberlain DA. Role of labetalol in acute myocardial infarction. Br J Clin Pharmacol 1982; 13(1 Suppl): 111S-4S
  11. ECG Learning Center, University of Utah. Introduction to ECG recognition of myocardial infarction [Online]. [cited 2016]; Available from: http://ecg.utah.edu/lesson/9
  12. Killip T 3rd, Kimball JT. Treatment of myocardial infarction in a coronary care unit. Am J Cardiol 1967; 20(4): 457-64.
  13. Fujiwara H, Sakurai M, Namai A, Kawamura T. Effect of low-dose landiolol, an ultrashort-acting beta-blocker, on postoperative atrial fibrillation after CABG surgery. Gen Thorac Cardiovasc Surg 2009; 57(3): 132-7.
  14. Brandler E, Paladino L, Sinert R. Does the early administration of beta-blockers improve the in-hospital mortality rate of patients admitted with acute coronary syndrome? Acad Emerg Med 2010; 17(1): 1-10.
  15. Malesker MA, Hilleman DE. Intravenous labetalol compared with intravenous nicardipine in the management of hypertension in critically ill patients. J Crit Care 2012; 27(5): 528-14.
Journal of Isfahan Medical School
Volume 34, Issue 386 - Serial Number 386
May and June 2016
Pages 663-669

  • Receive Date 10 April 2016
  • Accept Date 06 April 2022